IOVA - Iovance Biotherapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.2B
Enterprise Value 3763.95M
Trailing P/E N/A
Forward P/E 1-7.38
PEG Ratio (5 yr expected) 10.45
Price/Sales (ttm)N/A
Price/Book (mrq)3.39
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-7.23

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-31.54%
Return on Equity (ttm)-52.63%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -105.73M
Net Income Avi to Common (ttm)-105.18M
Diluted EPS (ttm)-1.35
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)276.1M
Total Cash Per Share (mrq)2.89
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)19.73
Book Value Per Share (mrq)2.92

Cash Flow Statement

Operating Cash Flow (ttm)-84.18M
Levered Free Cash Flow (ttm)-43.61M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.07
52-Week Change 360.59%
S&P500 52-Week Change 37.95%
52 Week High 319.90
52 Week Low 36.60
50-Day Moving Average 312.47
200-Day Moving Average 314.03

Share Statistics

Avg Vol (3 month) 31.41M
Avg Vol (10 day) 32.68M
Shares Outstanding 5120.89M
Float 84.68M
% Held by Insiders 11.44%
% Held by Institutions 192.11%
Shares Short (Sep 28, 2018) 410.27M
Short Ratio (Sep 28, 2018) 46.41
Short % of Float (Sep 28, 2018) 412.71%
Short % of Shares Outstanding (Sep 28, 2018) 410.74%
Shares Short (prior month Aug 31, 2018) 48.21M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/100
Last Split Date 3Sep 26, 2013